Tyrosine Kinases / Adaptors

Phospho-EGF Receptor (Tyr1068) Blocking Peptide

イイネ!(0)
CSTコード 包装
希望納入価格 (円)
国内在庫 i
2012年2月3日18時20分 現在
ご登録代理店情報 i
カスタマー情報にご登録いただいた代理店を表示しています。
ご登録代理店の変更はこちら
#1110S100 μg16,000
ログインすると国内在庫状況がご確認いただけます。

EGFR抗体製品一覧

用途
ウェスタンブロッティング、免疫組織染色
貯法
-20℃
使用目的
Phospho-EGF Receptor (Tyr1068)Antibody (#2234)とPhospho-EGF Receptor
(Tyr1068) (D7A5) XP® Rabbit mAb (#3777)の反応をブロックし、抗体の反応特異性を確認するために使用
社内データ

Western Blotting

Western Blotting

Western blot analysis of extracts from A431 cells, untreated or EGF-stimulated, using Phospho-EGF Receptor (Tyr1068) Antibody #2234 (left) or the same antibody preincubated with Phospho-EGF Receptor (Tyr1068) Antibody Blocking Peptide (right).

バックグラウンド

The epidermal growth factor (EGF) receptor is a transmembrane tyrosine kinase that belongs to the HER/ErbB protein family. Ligand binding results in receptor dimerization, autophosphorylation, activation of downstream signaling, internalization, and lysosomal degradation (1,2). Phosphorylation of EGF receptor (EGFR) at Tyr845 in the kinase domain is implicated in stabilizing the activation loop, maintaining the active state enzyme, and providing a binding surface for substrate proteins (3,4). c-Src is involved in phosphorylation of EGFR at Tyr845 (5). The SH2 domain of PLCγ binds at phospho-Tyr992, resulting in activation of PLCγ-mediated downstream signaling (6). Phosphorylation of EGFR at Tyr1045 creates a major docking site for the adaptor protein c-Cbl, leading to receptor ubiquitination and degradation following EGFR activation (7,8). The GRB2 adaptor protein binds activated EGFR at phospho-Tyr1068 (9). A pair of phosphorylated EGFR residues (Tyr1148 and Tyr1173) provide a docking site for the Shc scaffold protein, with both sites involved in MAP kinase signaling activation (2). Phosphorylation of EGFR at specific serine and threonine residues attenuates EGFR kinase activity. EGFR carboxy-terminal residues Ser1046 and Ser1047 are phosphorylated by CaM kinase II; mutation of either of these serines results in upregulated EGFR tyrosine autophosphorylation (10).

  1. Hackel, P.O. et al. (1999) Curr Opin Cell Biol 11, 184-9.
  2. Zwick, E. et al. (1999) Trends Pharmacol Sci 20, 408-12.
  3. Cooper, J.A. and Howell, B. (1993) Cell 73, 1051-4.
  4. Hubbard, S.R. et al. (1994) Nature 372, 746-54.
  5. Biscardi, J.S. et al. (1999) J Biol Chem 274, 8335-43.
  6. Emlet, D.R. et al. (1997) J Biol Chem 272, 4079-86.
  7. Levkowitz, G. et al. (1999) Mol Cell 4, 1029-40.
  8. Ettenberg, S.A. et al. (1999) Oncogene 18, 1855-66.
  9. Rojas, M. et al. (1996) J Biol Chem 271, 27456-61.
  10. Feinmesser, R.L. et al. (1999) J Biol Chem 274, 16168-73.
使用例
製品をご使用いただいて研究を発表されましたら、ぜひお知らせください
 
関連製品
2234   Phospho-EGF Receptor (Tyr1068) Antibody
3777   Phospho-EGF Receptor (Tyr1068) (D7A5) XP® Rabbit mAb
8102   SignalSlide® Phospho-EGF Receptor IHC Controls

本製品は試験研究用です。

Phospho-EGF Receptor (Tyr1068) Blocking Peptide

Product Pathways

Tools

Applications